[ad_1]
Key news from the Proactive Investors UK press room.
The long-awaited feasibility study on the Asiamet BKM project (LON: ARS) was released this morning and revealed an initial 9 year life span, producing up to 25,000 tonnes of copper cathode per year. The after-tax NPV is $ 133.5 million.
Immotion Group PLC (LON: IMMO) has signed a three-year contract with Survios, a virtual reality (VR) studio supported by media company MGM, to install content in its new VR Arena.
Faron Pharmaceuticals Oy (LON: FARN) released the final results of the YODA study on its drug, interferon beta Traumakine. A phase III clinical trial – called "INTEREST" – on patients with a syndrome called acute respiratory distress syndrome did not produce the expected results and the YODA study was asked to determine why.
The Exscientia holding company of the PLC Group Frontier IP Group (LON: FIPP) has undertaken a collaboration in drug discovery with the biotech GT Apeiron Therapeutics, based in Shanghai. As part of this partnership, Exscientia was entitled to become a shareholder of GT Apeiron and receive milestone payments and royalties based on the clinical and commercial success of its drug discovery program.
Source link
